Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecke... ( RICHMOND Calif. Oct. 1 /- Lumipho...)

HOME >> BIOLOGY >> TECHNOLOGY

Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board

Date:9/30/2008

RICHMOND, Calif., Oct. 1 /PRNewswire/ -- Lumiphore, Inc., a biotechnology leader in the development of new proprietary fluorescent metal-lanthanide technology for use in high-value applications, announced that it has signed an exclusive agreement with Biophor Diagnostics, Inc., Redwood City, California to apply Lumiphore products in diagnostic tests for drugs of abuse.

Under the agreement, Biophor Diagnostics holds the exclusive worldwide rights to Lumi4(TM) technology in current and future diagnostic tests of this type. Lumi4(TM) fluorescent metal-reporter compounds bring increased sensitivity, stability, and robustness to assays in the drugs of abuse testing market through their excellent fade-resistant photophysical properties.

This is the third strategic partnership reached by Lumiphore in the past three years. Previous partnerships include Cis Bio International (http://www.htrf.com/company/partners/) for the drug discovery research market and Echelon Biosciences Inc. (http://www.echelon-inc.com) for novel cancer assays involving phospholipid signaling and lipid-protein interactions.

The company today also announced the appointment of Dr. David J. Ecker to its board of directors. Dr. Ecker is Chief Scientific Officer and a founder of Ibis Biosciences and a co-founder and Vice President of Isis Pharmaceuticals. He brings to the board deep experience in successful biotech commercialization as well as specific technical expertise in detection and assay platforms.

Dr. Ecker has over 24 years of experience in the pharmaceutical/biotechnology industry in cancer and infectious disease research and development. He was a primary inventor of the Ibis T5000 biosensor technology, and has authored more than 80 scientific publications and over 50 U.S. patents. His extensive publications span biosensor technology, infectiou
'/>"/>

SOURCE Lumiphore, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related biology technology :

1. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
2. NuVasive to Present at Thomas Weisel Partners Healthcare Conference
3. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
4. GenVault Partnership with Genome Quebec Brings $3.3 Million Sale of Dynamic Archive Product
5. ADVENTRX Pharmaceuticals to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Caliper Life Sciences Presentation at Thomas Weisel Partners Healthcare Conference to be Webcast
7. SuperGen to Present at Thomas Weisel Partners Healthcare Conference September 5th
8. NxStage Medical to Present at the Thomas Weisel Partners Healthcare Conference on September 5, 2007
9. AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference
10. Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference
11. Thomas Weisel Partners 2007 Healthcare Conference To Webcast Millennium Presentation

Post Your Comments:

(Date:11/30/2009)...ire-USNewswire/ -- The Michael J. Fox Foundation f...5 million in total awards to six research teams wo...rapies for Parkinson,s disease. The funding was aw...y for Parkinson,s Disease program, made possible ... ), a neuroscience-based biotechnology company. ,...

(Date:11/30/2009).../ -- Dr. Jessica Torrente, Assistant Professor of ...Center in Washington, D.C., demonstrated the integ...SGI) in clinical practice as an adjunct imaging mo... the annual meeting of the Radiological Society of...xhibit was to demonstrate how BSGI is used in the ...

(Date:11/30/2009)... in providing smart and efficient software to the ...reg;, evolutionizing work-from-home histopathology... software used by 8 of the Top 10 Pharmaceutical C...ide’ basis. , Mount...s announced another evolution in the histopatholog...

(Date:11/30/2009)...er 30 ApaTech, the rapidly growing...t growing,Biotech/Pharmaceutical/Medical Technolog...y Fast 500 for EMEA (Europe, Middle East and Afric...ompanies, five-year revenue growth,for which ApaT.... This,achievement places ApaTech 9th overall in t...

Breaking Biology Technology:The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2 The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3 Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2 Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2 Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3 ApaTech is Europe's Fastest Growing Lifescience Company 2 ApaTech is Europe's Fastest Growing Lifescience Company 3 ApaTech is Europe's Fastest Growing Lifescience Company 4

[0] The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments [0] Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer [0] Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS [0] ApaTech is Europe's Fastest Growing Lifescience Company

...PPLICATION NOTE , , Cathy Olsen,...s Dr., , Sunnyvale, CA 94089. , ...The Molecular Devices SpectraMax M5 and, ...microplate readers whose detection modes include,... have dual, monochromators, so the optimi...

... Application Guide .........................................................................2 , ........................................................, II. Product Components ................................................................2 ,...

...urification of Endotoxin-Free Plasmid DNA , ,D... HP Endotoxin-Free Plasmid Maxiprep,Kit offers a...in-free plasmid DNA. A patent-pending,endotoxin ...t streamlined protocol available for purifying,h....,This product delivers significant time-savings...

measuring cell proliferation with SpectraMax M5, M2 and Gemini microplate readers using the CyQUANT Cell Proliferation Assay Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue Introducing,GenElute HP,Endotoxin-Free Plasmid,Maxiprep Kit

(Date:11/30/2009)...rom The Forsyth Institute, the University of Conne...nter, have used state-of-the-art technology to elu...lidum, the bacterium which causes syphilis. The pr...a can now be shown in three dimensions. This provi...ls previously unknown features, which may help fig...

(Date:11/30/2009)...rchers from LSU Health Sciences Center New Orleans...ational Institute of Child Health and Human Develo...igham and Women,s Hospital, and Harvard Medical Sc...more than 5 servings of sugar- sweetened cola a we...vate the risk of developing diabetes during pregna...

(Date:11/30/2009)...naugural Global Conference on Systems & Enterprise...gton, DC, focuses on the convergence of complex la...rtance to society. , The goal of the confere...round targeted complex systems, examined by domain...s Critical Infrastructure Systems, including Intel...

Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2 Sugary cola drinks linked for first time to higher risk of gestational diabetes 2 Sugary cola drinks linked for first time to higher risk of gestational diabetes 3 First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4 2 Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 1 Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 2 Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 3 Medpedia Project Expands Platform to Include Q 26amp 3BA News 26amp 3B Analysis and Alerts 61040 4 Top 10 Tips for Alzheimer 26apos 3Bs Caregivers 61036 1 Top 10 Tips for Alzheimer 26apos 3Bs Caregivers 61036 2 Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 1 Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 2 Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide 6117 3

[0] Scientists gain new understanding of disease-causing bacteria [0] Sugary cola drinks linked for first time to higher risk of gestational diabetes [0] First global conference on systems and enterprises at new Stevens location, Washington, DC, Dec. 3-4

...p-selling laundry products and air fresheners foun...ls. All six products tested gave off at least one ...eral laws, but none of those chemicals was listed ...n this topic because people were telling me that t...t from laundry products vented outdoors were makin...

...e working on new ways of storing CO 2 emissions u...ming. , The University has launched the Carbon St...ly-created position of Professor of Carbon Capture...to find efficient and reliable ways of gathering C...ng it in former oil and gas fields or aquifers ind...

...om the lower abdomen and inner thigh through lipos... cells, with higher stem cell concentrations than ... study in August,s Plastic and Reconstructive Sur...n Society of Plastic Surgeons (ASPS). This is the ...sues from different areas of the body vary in stem...

Other Biology News:Toxic chemicals found in common scented laundry products, air fresheners 2 Toxic chemicals found in common scented laundry products, air fresheners 3 Durham scientists to tackle CO2 storage in global warming challenge 2 Want a reason to love your lower belly fat? It's rich in stem cells 2

Toxic chemicals found in common scented laundry products, air fresheners Durham scientists to tackle CO2 storage in global warming challenge Want a reason to love your lower belly fat? It's rich in stem cells

Normal Chicken Serum from Equitech-Bio

Mouse Anti-Human HAPLN1 Monoclonal Antibody, Unconjugated, Clone 316119 from R&D Systems

Anti-Myelin Basic Protein (MBP), aa 129-138 Monoclonal Antibody, Unconjugated, Clone clone 1 from CHEMICON

SEQUENASE PCR PRODUCT PRE-SEQU from GE Healthcare, formerly Amersham Biosciences

Biology Products:

Normal Chicken Serum from Equitech-Bio Mouse Anti-Human HAPLN1 Monoclonal Antibody, Unconjugated, Clone 316119 from R&D Systems Anti-Myelin Basic Protein (MBP), aa 129-138 Monoclonal Antibody, Unconjugated, Clone clone 1 from CHEMICON SEQUENASE PCR PRODUCT PRE-SEQU from GE Healthcare, formerly Amersham Biosciences

Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecke...( RICHMOND Calif. Oct. 1 /- Lumipho...)